The store will not work correctly when cookies are disabled.
9-(5-Bromo-1H-indol-3-yl)-3,4,6,7-tetrahydroacridine-1,8-(2H,5H,9H,10H)-dione
ID: ALA3121554
PubChem CID: 76310821
Max Phase: Preclinical
Molecular Formula: C21H19BrN2O2
Molecular Weight: 411.30
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: O=C1CCCC2=C1C(c1c[nH]c3ccc(Br)cc13)C1=C(CCCC1=O)N2
Standard InChI: InChI=1S/C21H19BrN2O2/c22-11-7-8-14-12(9-11)13(10-23-14)19-20-15(3-1-5-17(20)25)24-16-4-2-6-18(26)21(16)19/h7-10,19,23-24H,1-6H2
Standard InChI Key: MTTFVVBOBKGJFN-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 30 0 0 0 0 0 0 0 0999 V2000
3.0462 -15.7560 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3262 -15.7686 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6031 -17.0043 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0462 -16.5810 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7583 -16.9894 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7583 -15.3392 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4704 -15.7560 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4669 -16.5810 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1757 -16.9942 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.1827 -15.3441 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8961 -15.7620 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8923 -16.5896 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6108 -15.3492 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6134 -14.5241 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.7583 -14.5141 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.1851 -14.5190 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8551 -14.0398 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6060 -13.2545 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.3253 -16.5954 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5202 -14.0360 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7766 -13.2543 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2284 -12.6434 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4236 -12.8130 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1700 -13.5989 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7198 -14.2064 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3632 -13.7724 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
1 4 1 0
1 6 1 0
4 5 1 0
5 8 1 0
7 6 1 0
7 8 2 0
7 10 1 0
8 9 1 0
9 12 1 0
11 10 1 0
11 12 2 0
11 13 1 0
12 3 1 0
3 19 1 0
2 13 1 0
13 14 2 0
6 15 2 0
10 16 1 0
16 17 2 0
17 18 1 0
20 16 1 0
21 18 1 0
19 2 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 20 1 0
24 26 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 411.30 | Molecular Weight (Monoisotopic): 410.0630 | AlogP: 4.63 | #Rotatable Bonds: 1 |
Polar Surface Area: 61.96 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 3.27 | CX LogD: 3.27 |
Aromatic Rings: 2 | Heavy Atoms: 26 | QED Weighted: 0.72 | Np Likeness Score: -0.56 |
References
1. Gündüz MG, Işli F, El-Khouly A, Yıldırım S, Öztürk Fincan GS, Şimşek R, Şafak C, Sarıoğlu Y, Öztürk Yıldırım S, Butcher RJ.. (2014) Microwave-assisted synthesis and myorelaxant activity of 9-indolyl-1,8-acridinedione derivatives., 75 [PMID:24534541] [10.1016/j.ejmech.2014.01.059] |